AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimnis MF Tablet

Prescription Icon
Prescription Required

Marketer

Adonis Laboratories Pvt Ltd

Salt Composition

Glimepiride (NA) + Metformin (NA)

Overview Glimnis MF Tablet

Diabex Duo tablets are a dual-action antidiabetic medication prescribed for adult patients with type 2 diabetes. This combination therapy effectively manages blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, Diabex Duo is one component of a comprehensive diabetes management plan, including a healthy diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize its symptoms—sweating, dizziness, headache, trembling—and know how to counteract it with readily available glucose (e.g., sugary foods or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. Diabex Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with potential blood tests for complete blood count and liver function, are recommended by your doctor.

Uses of Glimnis MF Tablet

Managing type 2 diabetes

Major Benefits of Glimnis MF Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimnis MF Tablet with a meal.

Common Side effects of Glimnis MF Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimnis MF Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimnis MF Tablet with a meal.

How Glimnis MF Tablet works:

Glimnis MF Tablet combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimnis MF Tablet with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimnis MF Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against these risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glimnis MF Tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glimnis MF Tablets cautiously, potentially requiring dosage modification under medical supervision. The medication is contraindicated in individuals with severely compromised kidney function. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimnis MF Tablet cautiously, potentially requiring dosage modification. Consult a physician for guidance. A low initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glimnis MF Tablet :

Should you forget a Glimnis MF Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Glimnis MF Tablet

LabelValue
Addictive None.
Medication Classification Diabetes medication

FAQs on Glimnis MF Tablet

Retain this medication in its original, sealed container. Follow the storage guidelines printed on the packaging. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Glimnis MF Tablet use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms can include muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If such symptoms appear, discontinue Glimnis MF Tablet and seek immediate medical attention.
Glimnis MF Tablet combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used with a balanced diet and physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and increases insulin responsiveness. This combination therapy is unsuitable for type 1 diabetes.
Glimnis MF Tablet may cause common adverse reactions including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious side effects such as lactic acidosis may occur. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimnis MF Tablet use can indeed lead to Vitamin B12 deficiency by hindering its absorption within the gastrointestinal tract. This deficiency, if left unaddressed, may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and gait instability. Preventive strategies proposed by some studies include supplemental Vitamin B12 intake at least annually.
Glimnis MF Tablets can induce hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar include nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available source of glucose, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glimnis MF Tablet and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and a heightened probability of lactic acidosis.
Glimnis MF Tablet
40
MRP 49
17% off